龙莉莉,伍桂雄

肺癌是中国死亡率和发病率最高的恶性肿瘤，早期诊断、早期治疗是改善肺癌患者预后的关键。尽管许多肺癌筛查实验中已经证明，通过早期筛查提高早期肺癌检出率可降低所有人群肺癌死亡率，但我国肺癌筛查仍面临诸多挑战，本文将对肺癌早期筛查的相关研究进行归纳整理，拟在为建立精确肺癌筛查模型提供一定的参考。

肺癌；早期筛查；高危人群；经济效益

[1] BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263. [2] FIELD J K,DUFFY S W,BALDWIN D R,et al.The UK Lung Cancer Screening Trial:a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer[J].Health Technol Assess,2016,20(40):1-146. [3] NAIDICH D P,MARSHALL C H,GRIBBIN C,et al.Low-dose CT of the lungs:preliminary observations[J].Radiology,1990,175(3):729-731. [4] KANEKO M,EGUCHI K,OHMATSU H,et al.Peripheral lung cancer:screening and detection with low-dose spiral CT versus radiography[J].Radiology,1996,201(3):798-802. [5] ABERLE D R,ADAMS A M,BERG C D,et al.Reduced lung-cancer mortality with low-dose computed tomographic screening[J].N Engl J Med,2011,365(5):395-409. [6] van IERSEL C A,de KONING H J,DRAISMA G,et al.Risk-based selection from the general population in a screening trial:selection criteria,recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial(NELSON)[J].Int J Cancer, 2007,120(4):868-874. [7] LI N,TAN F,CHEN W,et al.One-off low-dose CT for lung cancer screening in China:a multicentre,population-based,prospective cohort study[J].Lancet Respir Med,2022,10(4):378-391. [8] 唐威,吴宁,黄遥,等.4690例无症状健康体检者低剂量CT早期肺癌筛查研究[J].中华肿瘤杂志,2014,36(7):549-554. [9] KRIST A H,DAVIDSON K W,MANGIONE C M,et al.Screening for Lung Cancer:US Preventive Services Task Force Recommendation Statement[J].JAMA,2021,325(10):962-970. [10] JI G,BAO T,LI Z,et al.Current lung cancer screening guidelines may miss high-risk population:a real-world study[J].BMC Cancer, 2021,21(1):50. [11] 中华医学会呼吸病学分会,中国肺癌防治联盟专家组.肺结节诊治中国专家共识(2024年版)[J].中华结核和呼吸杂志, 2024,47(8):716-729. [12] LI N,TAN F,CHEN W,et al.One-off low-dose CT for lung cancer screening in China:a multicentre,population-based,prospective cohort study[J].Lancet Respir Med,2022,10(4):378-391. [13] BARTLETT E C,SILVA M,CALLISTER M E,et al.False-Negative Results in Lung Cancer Screening-Evidence and Controversies[J].J Thorac Oncol,2021,16(6):912-921. [14] 中华医学会呼吸病学分会.早期肺癌诊断中国专家共识(2023年版)[J].中华结核和呼吸杂志,2023,46(1):1-18. [15] 孔海涛,郭子祺,刘婷婷.人工智能技术结合低剂量方案在胸部CT成像中的应用研究探讨[J].罕少疾病杂志,2024,31(12):75-76. [16] 刘亚斌,周围,白琛,等.基于人工智能技术的肺部CT扫描在肺结节筛查及良恶性鉴别诊断中的应用分析[J].中国CT和MRI杂志,2022,20(09):52-54. [17] 王葵,刘丽娟,金观桥.人工智能在低剂量螺旋CT早期肺癌筛查中的应用进展[J].放射学实践,2025,40(05):672-676. [18] 刘艳雯,曾庆思,邓宇,等.人工智能在胸部低剂量CT肺结节检出中的效能评价[J].中华生物医学工程杂志,2022,28(6):638-644. [19] 李萍,王学东,建奇伟,等.血清肿瘤标志物在肺癌诊断中的价值[J].国际检验医学杂志,2025,46(13):1586-1590. [20] 巫圣美.血清CYFRA21-1､CA125､CEA､NSE及SCCA联合检测在肺癌诊断中的价值[J].中国医药指南,2024,22(34):47-50. [21] CHAPMAN C J,MURRAY A,MCELVEEN J E,et al.Autoantibodies in lung cancer:possibilities for early detection and subsequent cure[J].Thorax,2008,63(3):228-233. [22] MU Y,XIE F,SUN T.Clinical value of seven autoantibodies combined detection in the diagnosis of lung cancer[J].J Clin Lab Anal,2020,34(8):e23349. [23] 张伟,贾玉昌,宋朝晖.低剂量螺旋CT联合7-TAAB､CEA､CYFRA21-1对肺癌的诊断价值[J].中国卫生工程学,2025,24(03):384-386. [24] 崔丽荣,马苇萍,张翔.7种肿瘤相关自身抗体在肺癌诊断中应用的研究进展[J].免疫学杂志,2025,41(03):193-198. [25] 张文静,宋紫嫣,李浩,等.肺癌循环肿瘤细胞检测新进展[J].中国医药生物技术,2025,20(Z1):31-34,66. [26] ILIE M,HOFMAN V,LONG-MIRA E,et al."Sentinel"circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease[J].PLoS One,2014,9(10):e111597. [27] 肖鹏,梅家转,李瑞君,等.外周血循环肿瘤细胞在不同阶段和不同类型肺癌中的价值研究[J].癌症进展,2018,16(06):763-765. [28] 唐弋博,刘莉,吉正国,等.循环肿瘤DNA检测技术在肿瘤精准医疗中的应用进展[J].中国医刊,2025,60(08):875-878. [29] ABERLE D R,ADAMS A M,BERG C D,et al.Reduced lung-cancer mortality with low-dose computed tomographic screening[J].N Engl J Med,2011,365(5):395-409. [30] 杨庆,刘德,娄培安,等.2014-2019年徐州市城市居民肺癌筛查结果及成本-效果分析[J].中华肿瘤防治杂志,2022,29(07):463-467.

点击下载PDF